Home

LFB Biotechnologies S.A.S.U.

CIK 1377942 · Director by Deputization · last filed 2015-05-11

LFB Biotechnologies S.A.S.U. is a Director by Deputization who has filed 8 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for TGTX, was dated May 11, 2015. Across all open-market trades the lifetime net is +$10.6M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $436.4M across reported positions. The firm reports its address in Courtaboeuf, I0.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$436.41M

Companies

2

Total Filings

8

Lifetime Open-Market Net

$10.60M

Filer Profile

Reported Address
3 AVENUE DES TROPIQUES
LES ULIS
COURTABOEUF, I0 91958
Phone
33 6 33554531
State of Incorporation
France
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TGTX 10%+ Owner 7,614,855 $57.31 $436.41M $750.0K 1 2015-05-11
GTC BIOTHERAPEUTICS INC (GTCB) Delisted Director 21,299,906 — — $9.85M 6 2010-01-08

Recent Filings

8 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2015-05-11 TGTX Mixed +2,614,855 $752.5K EDGAR
2010-06-17 — Buy (P) — $0
2010-01-08 GTC BIOTHERAPEUTICS INC (GTCB) Delisted Conv (C) +5,299,071 $12.75M EDGAR
2009-11-04 GTC BIOTHERAPEUTICS INC (GTCB) Delisted Mixed +13,985,995 $29.12M EDGAR
2008-12-31 GTC BIOTHERAPEUTICS INC (GTCB) Delisted Buy (P) — $0 EDGAR
2008-03-27 GTC BIOTHERAPEUTICS INC (GTCB) Delisted Conv (C) +14,500,000 $0 EDGAR
2008-02-25 GTC BIOTHERAPEUTICS INC (GTCB) Delisted Buy (P) +2,018,404 $1.76M EDGAR
2007-01-05 GTC BIOTHERAPEUTICS INC (GTCB) Delisted Buy (P) +3,630,000 $4.46M EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.